pharma

Showing 15 posts of 2914 posts found.

cancer-cell

Independent research may change the immunotherapy game

August 17, 2017
Research and Development Cancer, biotech, drugs, immunotherapy, pharma, pharmaceutical

Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …

FDA recalls liquid pharma products after bacterial contamination detected

August 17, 2017
Medical Communications, Sales and Marketing FDA, life sciences, pharma, pharmaceutical

The FDA has announced that it has been forced to recall a range of liquid pharmaceutical and dietary supplement products …

Alexion moves to bolster patent protection of Soliris

August 17, 2017
Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris

Soliris brought in net sales of $2.8 billion last year for Alexion, meaning it accounted for close to 90% of …

novo_flag

Novo diabetes drug outperforms Lilly rival at Phase 3

August 17, 2017
Research and Development Eli Lilly, Novo Nordisk, diabetes, life sciences, medicine, pharma, pharmaceutical, type 2 diabetes

Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …

microscope-275984_960_720

Cancer Research UK and NU agree three-year research Astex Pharma deal

August 17, 2017
Research and Development, Sales and Marketing Astex pharmaceuticals, Cancer Research UK, Newcastle University, biotech, drugs, pharma, pharmaceutical

Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for …

shutterstock

New personalised molecular blood test could shake up cancer treatment

August 16, 2017
Research and Development Cancer, life sciences, medicine, pharma, pharmaceutical, standford university

A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer which …

old-peoples-home-524234_960_720

Massive increase in UK care home places needed by 2025, report finds

August 16, 2017
Research and Development UK, UK government, biotech, drugs, pharma, pharmaceutical, social care

A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …

opdivo_1_1

BMS left red-faced as Opdivo+Yervoy fails to beat rival Pfizer drug in kidney cancer

August 16, 2017
Research and Development BMS, Kidney cancer, Yervoy, life sciences, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has been left somewhat red-faced after its combination of Opdivo (nivolumab) and Yervoy (ipilimumab) failed to show any …

baby-1151345_960_720

Less sleep in children linked to increased risk of diabetes

August 16, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical, type 2, type-2

A study emerging from St George’s University of London found that children who slept an hour less than the recommended …

heart_patch

Mending broken hearts with an injectable patch

August 16, 2017
Research and Development biotech, cardiovascular, drugs, heart disease, pharma, pharmaceutical

A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …

shire_image

Shire submits dry-eye drug for marketing approval

August 15, 2017
Manufacturing and Production, Sales and Marketing Shire, biotech, drugs, pharma, pharmaceutical

Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …

gilead-sciences

Gilead set to open $250m, 23-acre campus

August 15, 2017
Manufacturing and Production Gilead, biotech, drugs, pharma, pharmaceutical

Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of …

regeneron

Regeneron abandons respiratory syncytial virus therapy after late-stage failure

August 15, 2017
Manufacturing and Production, Research and Development RSV, Regeneron, pharma, pharmaceuticals, respiratory syncytial virus

Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the …

Mundipharma agrees $250m ‘smart chemotherapy’ deal

August 15, 2017
Manufacturing and Production, Sales and Marketing CellAct, Mundipharma, biotech, drugs, pharma, pharmaceutical

A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits …

The Gateway to Local Adoption Series

Latest content